USP quinquennial meeting
Executive Summary
Comments by Reza Fassihi, PhD, Temple University School of Pharmacy, regarding in vitro dissolution methods to show bioequivalence were misattributed in the May 1 issue of "The Pink Sheet" (p. 31). "If we are going to base our biopharmaceutics approach on dissolution methods that are currently in the USP, I think you are on the wrong track," Fassihi said